Life Science/Healthcare
Long a core vertical for Rodman, we continue to expand our excellence and expertise in life science and healthcare. Our investment bankers provide the full range of advisory and corporate finance services to public and private firms in this key sector, concentrating on building deep, broad and long-term relationships with senior management and investors. We provide capital and advice throughout all stages of life science companies’ development and routinely provide repeat services for our clients.
Since 2003, Rodman has completed over 230 transactions and raised over $3.7 billion for healthcare companies.
Click here, for Selected Transactions.
Our research analysts include PhDs and other experienced clinicians and researchers, providing both scientific depth and commercial sensibility to a broad range of companies in the sector.
Click here, for Equity Research Coverage.
Rodman’s commitment to life science and healthcare goes beyond its role as an advisor. In 2008, we formed a merchant banking joint venture, Aceras Biomedical LLC, bringing to our franchise a premier team for biotechnology and life science investing. Aceras Biomedical is a unique investment firm that joins strong industry expertise and dedicated capital to offer partnership opportunities and flexible investment structures to public and private healthcare companies. Aceras identifies and supports the development of promising products in all stages of development and commercialization. For more information about Aceras, contact Daniel DiPietro at 212.430.1739.
Click here, for Rodman & Renshaw Annual Healthcare Conference